These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28296603)

  • 21. A high proportion of users of low-threshold facilities with needle exchange programmes in Switzerland are currently on methadone treatment: implications for new approaches in harm reduction and care.
    Gervasoni JP; Balthasar H; Huissoud T; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2012 Jan; 23(1):33-6. PubMed ID: 21705205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal poisoning in methadone and buprenorphine treated patients -- are there differences?
    Soyka M; Penning R; Wittchen U
    Pharmacopsychiatry; 2006 May; 39(3):85-7. PubMed ID: 16721696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facing the Growing Heroin Problem in Colombia: The New Methadone-assisted Treatment Programs.
    González G; Giraldo LF; DiGirolamo G; Rey CF; Correa LE; Cano AM; Romero-González M
    Rev Colomb Psiquiatr (Engl Ed); 2019; 48(2):96-104. PubMed ID: 30981333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: purpose of misuse and route of administration.
    Hakansson A; Medvedeo A; Andersson M; Berglund M
    Eur Addict Res; 2007; 13(4):207-15. PubMed ID: 17851242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.
    Marotta PL; McCullagh CA
    Eur J Epidemiol; 2018 Jul; 33(7):679-688. PubMed ID: 29234968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania.
    Ubuguyu O; Tran OC; Bruce RD; Masao F; Nyandindi C; Sabuni N; McCurdy S; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():74-81. PubMed ID: 27017376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatic health among heroin addicts before and during opioid maintenance treatment: a retrospective cohort study.
    Skeie I; Brekke M; Lindbaek M; Waal H
    BMC Public Health; 2008 Jan; 8():43. PubMed ID: 18237421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug substitution therapy: a new approach in preventing the spread of HIV/AIDS in Malaysia.
    Razali SM
    Trop Doct; 2008 Apr; 38(2):109-10. PubMed ID: 18453507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bilateral candida endophthalmitis in 2 i. v. drug-dependent patients with oral L-methadone substitution].
    Möller M; Althaus C; Sundmacher R
    Klin Monbl Augenheilkd; 1997 Jul; 211(1):53-6. PubMed ID: 9340407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of opioid dependence and cancer pain with sublingual buprenorphine: a case report.
    Park EM; Suzuki J
    Am J Addict; 2012; 21(3):283-4. PubMed ID: 22494234
    [No Abstract]   [Full Text] [Related]  

  • 31. Methadone diversion as a protective strategy: the harm reduction potential of 'generous constraints'.
    Harris M; Rhodes T
    Int J Drug Policy; 2013 Nov; 24(6):e43-50. PubMed ID: 23199896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics.
    Groshkova T; Metrebian N; Hallam C; Charles V; Martin A; Forzisi L; Lintzeris N; Strang J
    Drug Alcohol Rev; 2013 Nov; 32(6):566-73. PubMed ID: 24118500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Substitution of drug-dependent HIV patients with levomethadone].
    Becker-Boost I; Phlippen R
    Med Klin (Munich); 1993 May; 88(5):300-3. PubMed ID: 8326917
    [No Abstract]   [Full Text] [Related]  

  • 34. Supervised injection facilities in Canada: past, present, and future.
    Kerr T; Mitra S; Kennedy MC; McNeil R
    Harm Reduct J; 2017 May; 14(1):28. PubMed ID: 28521829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Buprenorphine for human immunovirus-positive opiate-dependent patients.
    Montoya ID; Umbricht A; Preston KL
    Biol Psychiatry; 1995 Jul; 38(2):135-6. PubMed ID: 7578651
    [No Abstract]   [Full Text] [Related]  

  • 36. Overdose prevention sites and heroin assisted treatment.
    Sherman S
    BMJ; 2019 Sep; 366():l5437. PubMed ID: 31501227
    [No Abstract]   [Full Text] [Related]  

  • 37. Mitigating the heroin crisis in Baltimore, MD, USA: a cost-benefit analysis of a hypothetical supervised injection facility.
    Irwin A; Jozaghi E; Weir BW; Allen ST; Lindsay A; Sherman SG
    Harm Reduct J; 2017 May; 14(1):29. PubMed ID: 28532488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcomes after 3-month methadone maintenance treatment between heroin users with and without HIV infection: a 3-month follow-up study.
    Wang PW; Lin HC; Yen CN; Yeh YC; Hsu CY; Chung KS; Chang HC; Wu HC; Yen CF
    Harm Reduct J; 2015 May; 12():13. PubMed ID: 25953093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The risk behavior of drug addicts requires holistic approach from the society. Syringe exchange and methadone-/buprenorphine treatment are important elements].
    Håkansson AC
    Lakartidningen; 2012 Jun 19-26; 109(25):1216-7. PubMed ID: 22838110
    [No Abstract]   [Full Text] [Related]  

  • 40. Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment.
    Man LH; Best D; Gossop M; Stillwell G; Strang J
    Eur Addict Res; 2004; 10(1):35-40. PubMed ID: 14665804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.